INDUSTRY INSIGHTS YOUR PEERS ARE READING
Insights on Pharmaceuticals & Medical ProductsMedical affairs is poised for a broader, more strategic role. However, leaders will need to ramp up new types of capabilities and talent to achieve this ambition. MORE
Insights on Pharmaceuticals & Medical ProductsThe president and CEO of JSR Corporation discusses the company’s plans to grow a global healthcare franchise building from his lessons in the semiconductor industry. MORE
And although the pharmaceutical and healthcare industries know this is the way forward, they face some significant hurdles Precision medicine combines business opportunities with clinical health benefits. MORE
Insights on Pharmaceuticals & Medical ProductsFive facts showing that companies should invest in digital customer engagement in Japan. MORE
Insights on Pharmaceuticals & Medical ProductsMany pharma and medtech companies have a digital strategy. But to pull off a true digital transformation, it's crucial to focus on culture and mindset, according to leaders who attended a recent European roundtable. MORE
Insights on Pharmaceuticals & Medical ProductsWhile there is general agreement that real-world evidence could significantly improve how healthcare stakeholders make decisions, expanding its use requires action by multiple stakeholders. MORE
Insights on Pharmaceuticals & Medical ProductsFor medtech companies, divestitures can create value. But several elements are necessary to make separations successful. MORE
Insights on Pharmaceuticals & Medical ProductsValue-based procurement is a reality today. To capture the opportunity in today’s European medtech-public-procurement market fully, winners need to adapt to new realities quickly. MORE
Insights on Pharmaceuticals & Medical ProductsAs the prevalence and severity of cancer has increased, the drug landscape has shifted. Oncology launches are increasingly critical and require a dedicated approach. Here’s what it entails. MORE
Insights on Pharmaceuticals & Medical ProductsDesign can help craft a standout patient experience. Here, three leaders discuss how the discipline is improving medical products and driving innovation. MORE
Insights on Pharmaceuticals & Medical ProductsThe president of Merck in Japan discusses how healthcare players in the country can capitalize on early detection rates and use collaboration to drive innovation. MORE
Insights on Pharmaceuticals & Medical ProductsEmerging technologies can make quality control (QC) faster and more efficient. What do pharma companies need to do to become QC leaders? MORE
The CEO of Eli Lilly offers perspectives on accelerating change in the industry. Our Insights MORE
Insights on Pharmaceuticals & Medical ProductsTwo Merck Healthcare digital specialists explain their company’s transformation and the impact it has had on patients. MORE
Insights on Pharmaceuticals & Medical ProductsIn increasingly crowded drug markets, a strong clinical profile is no longer enough to ensure a distinctive launch. To be successful, pharma companies need to launch not only products but also experiences. MORE
Insights on Pharmaceuticals & Medical ProductsJaak Peeters, head of global public health at Johnson & Johnson, discusses the role pharma can play in addressing big challenges, such as fighting diseases like HIV and tuberculosis. MORE
Insights on Pharmaceuticals & Medical ProductsIn a sector undergoing unprecedented change, five muscles will define the successful leaders of the future. MORE
Insights on Pharmaceuticals & Medical ProductsEsteban Santos, executive vice president for operations at Amgen, explains how the company is using operations to support innovation. MORE
Insights on Pharmaceuticals & Medical ProductsIn this interview, Peter Marks of the US Food and Drug Administration discusses how the organization has contributed to the broader ecosystem of innovation. MORE
Insights on Pharmaceuticals & Medical ProductsThe potential for real-world evidence is expanding, particularly in oncology drug development. To compete, some companies are investing in robust real-world data and analytic capabilities. MORE
A McKinsey study points to areas pharmaceutical companies can address to combat this long-standing industry issue. Insights on Pharmaceuticals & Medical ProductsWhen patients fail to follow prescribed medical regimens, outcomes suffer. MORE
Insights on Pharmaceuticals & Medical ProductsUnderstanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients. MORE
Insights on Pharmaceuticals & Medical ProductsFive strategic efforts can help medical affairs teams master customer engagement in the digital age. MORE
Insights on Pharmaceuticals & Medical ProductsTo keep pace with the evolving ecosystem for precision medicine, pharma players must be attuned to three crucial components: data collection, individualized solutions, and supporting business models. MORE
That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The biggest change for pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Older people need more medicine. MORE
Insights on Pharmaceuticals & Medical ProductsMedical information teams can be a source of differentiation if used strategically. But the evolving environment means pharma manufacturers will need to make organizational enhancements to get ahead. MORE
Insights on Pharmaceuticals & Medical ProductsJacques Nathan, president of Sanofi Japan, discusses what’s ahead for his changing sector. MORE
A comprehensive analysis of the business, economic, and public-health impact finds the potential for local production of pharmaceuticals to be a mixed bag. Public Sector Insights MORE
1 Pharmaceutical companies are unique in their capacity, due to little regulation and oversight, to raise prices. Pharmaceutical companies focus on a variety of factors when pricing drugs with the main objective of generating the most revenue. Topic: Pharmaceutical Industry in the U.S.” MORE
Insights on Pharmaceuticals & Medical ProductsEnthusiasm for the biopharmaceutical sector in Asia has been flat, due in part to China’s market-access blockade, Japan’s spending controls, and deceleration in India and Southeast Asia. MORE
Insights on Pharmaceuticals & Medical ProductsDesign is increasingly a business imperative, but medtech companies have been slow to embrace it. What benefits might a focus on medical-device design bring, and how can companies get started? MORE
There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios. Strategy & Corporate Finance Insights MORE
Insights on Pharmaceuticals & Medical ProductsThe Head of Digital Strategy and Medical Innovation, US Clinical Development and Medical Affairs at Novartis discusses how disruptive technologies and digital innovation are inspiring a start-up mind-set within the organization. MORE
Insights on Pharmaceuticals & Medical ProductsAs innovation reshapes the pharma landscape, pharma companies will need to revisit their R&D operating models to thrive. MORE
Insights on Pharmaceuticals & Medical ProductsDigital promises to transform R&D productivity over the next decade. What will it take to realize this potential? MORE
Insights on Pharmaceuticals & Medical ProductsIn the biosimilars market, companies face declining prices and rising competition. What themes will shape the industry in coming months, and how can players set themselves apart? MORE
Insights on Pharmaceuticals & Medical ProductsEmerging technologies can make quality control (QC) faster and more efficient. What do pharma companies need to do to become QC leaders? MORE
Insights on Pharmaceuticals & Medical ProductsHow can medtech companies thrive in the world’s fastest-growing market? MORE
By going digital, biotech pioneers with promising biomolecular platforms are improving drug discovery and development—and changing the pharmaceutical industry. Insights on Pharmaceuticals & Medical Products MORE
Insights on Pharmaceuticals & Medical ProductsSix levers can help healthcare and pharma players achieve better outcomes when using machine learning. MORE
Insights on Pharmaceuticals & Medical ProductsAdvanced analysis of genomic data integrated with electronic medical records and other data sets, combined with effective reimbursement strategies and full data-regulatory compliance, will distinguish winning diagnostics companies. MORE
Pharmaceuticals Related Topics McKinsey
SEPTEMBER 1, 2018
Insights on Pharmaceuticals & Medical ProductsUnderstanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.
Strategy+Business
FEBRUARY 22, 2018
And although the pharmaceutical and healthcare industries know this is the way forward, they face some significant hurdles Precision medicine combines business opportunities with clinical health benefits.
McKinsey
OCTOBER 11, 2018
There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios. Strategy & Corporate Finance Insights
McKinsey
OCTOBER 27, 2017
The CEO of Eli Lilly offers perspectives on accelerating change in the industry. Our Insights
Harvard Business
MARCH 11, 2018
That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The biggest change for pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Older people need more medicine.
McKinsey
MARCH 15, 2019
Insights on Pharmaceuticals & Medical ProductsThe Head of Digital Strategy and Medical Innovation, US Clinical Development and Medical Affairs at Novartis discusses how disruptive technologies and digital innovation are inspiring a start-up mind-set within the organization.
|
McKinsey
MARCH 19, 2019
Insights on Pharmaceuticals & Medical ProductsFor medtech companies, divestitures can create value. But several elements are necessary to make separations successful.
McKinsey
DECEMBER 15, 2018
A McKinsey study points to areas pharmaceutical companies can address to combat this long-standing industry issue. Insights on Pharmaceuticals & Medical ProductsWhen patients fail to follow prescribed medical regimens, outcomes suffer.
McKinsey
NOVEMBER 6, 2018
Insights on Pharmaceuticals & Medical ProductsTwo Merck Healthcare digital specialists explain their company’s transformation and the impact it has had on patients.
McKinsey
NOVEMBER 9, 2018
Insights on Pharmaceuticals & Medical ProductsHow can medtech companies thrive in the world’s fastest-growing market?
McKinsey
JANUARY 5, 2019
Insights on Pharmaceuticals & Medical ProductsEmerging technologies can make quality control (QC) faster and more efficient. What do pharma companies need to do to become QC leaders?
|
|
McKinsey
FEBRUARY 7, 2019
Insights on Pharmaceuticals & Medical ProductsTo keep pace with the evolving ecosystem for precision medicine, pharma players must be attuned to three crucial components: data collection, individualized solutions, and supporting business models.
McKinsey
JULY 31, 2018
By going digital, biotech pioneers with promising biomolecular platforms are improving drug discovery and development—and changing the pharmaceutical industry. Insights on Pharmaceuticals & Medical Products
McKinsey
OCTOBER 13, 2018
Insights on Pharmaceuticals & Medical ProductsIn a sector undergoing unprecedented change, five muscles will define the successful leaders of the future.
McKinsey
AUGUST 11, 2018
Insights on Pharmaceuticals & Medical ProductsJacques Nathan, president of Sanofi Japan, discusses what’s ahead for his changing sector.
McKinsey
MARCH 7, 2018
Insights on Pharmaceuticals & Medical ProductsFive facts showing that companies should invest in digital customer engagement in Japan.
McKinsey
NOVEMBER 1, 2018
Insights on Pharmaceuticals & Medical ProductsAdvanced analysis of genomic data integrated with electronic medical records and other data sets, combined with effective reimbursement strategies and full data-regulatory compliance, will distinguish winning diagnostics companies.
McKinsey
OCTOBER 6, 2018
Insights on Pharmaceuticals & Medical ProductsAs innovation reshapes the pharma landscape, pharma companies will need to revisit their R&D operating models to thrive.
McKinsey
OCTOBER 12, 2018
Insights on Pharmaceuticals & Medical ProductsMany pharma and medtech companies have a digital strategy. But to pull off a true digital transformation, it's crucial to focus on culture and mindset, according to leaders who attended a recent European roundtable.
McKinsey
FEBRUARY 8, 2018
Insights on Pharmaceuticals & Medical ProductsDesign can help craft a standout patient experience. Here, three leaders discuss how the discipline is improving medical products and driving innovation.
McKinsey
JUNE 9, 2018
Insights on Pharmaceuticals & Medical ProductsEsteban Santos, executive vice president for operations at Amgen, explains how the company is using operations to support innovation.
McKinsey
JUNE 13, 2018
Insights on Pharmaceuticals & Medical ProductsJaak Peeters, head of global public health at Johnson & Johnson, discusses the role pharma can play in addressing big challenges, such as fighting diseases like HIV and tuberculosis.
McKinsey
JANUARY 23, 2019
Insights on Pharmaceuticals & Medical ProductsIn this interview, Peter Marks of the US Food and Drug Administration discusses how the organization has contributed to the broader ecosystem of innovation.
McKinsey
MAY 4, 2018
Insights on Pharmaceuticals & Medical ProductsFive strategic efforts can help medical affairs teams master customer engagement in the digital age.
McKinsey
JULY 25, 2018
Insights on Pharmaceuticals & Medical ProductsThe potential for real-world evidence is expanding, particularly in oncology drug development. To compete, some companies are investing in robust real-world data and analytic capabilities.
McKinsey
NOVEMBER 3, 2018
Insights on Pharmaceuticals & Medical ProductsDigital promises to transform R&D productivity over the next decade. What will it take to realize this potential?
McKinsey
DECEMBER 7, 2018
Insights on Pharmaceuticals & Medical ProductsValue-based procurement is a reality today. To capture the opportunity in today’s European medtech-public-procurement market fully, winners need to adapt to new realities quickly.
McKinsey
MAY 16, 2018
Insights on Pharmaceuticals & Medical ProductsEnthusiasm for the biopharmaceutical sector in Asia has been flat, due in part to China’s market-access blockade, Japan’s spending controls, and deceleration in India and Southeast Asia.
McKinsey
AUGUST 16, 2018
Insights on Pharmaceuticals & Medical ProductsIn increasingly crowded drug markets, a strong clinical profile is no longer enough to ensure a distinctive launch. To be successful, pharma companies need to launch not only products but also experiences.
McKinsey
MAY 8, 2018
Insights on Pharmaceuticals & Medical ProductsWhile there is general agreement that real-world evidence could significantly improve how healthcare stakeholders make decisions, expanding its use requires action by multiple stakeholders.
McKinsey
JANUARY 9, 2019
Insights on Pharmaceuticals & Medical ProductsEmerging technologies can make quality control (QC) faster and more efficient. What do pharma companies need to do to become QC leaders?
McKinsey
JULY 18, 2018
Insights on Pharmaceuticals & Medical ProductsDesign is increasingly a business imperative, but medtech companies have been slow to embrace it. What benefits might a focus on medical-device design bring, and how can companies get started?
McKinsey
JULY 18, 2018
Insights on Pharmaceuticals & Medical ProductsIn the biosimilars market, companies face declining prices and rising competition. What themes will shape the industry in coming months, and how can players set themselves apart?
McKinsey
AUGUST 3, 2018
Insights on Pharmaceuticals & Medical ProductsAs the prevalence and severity of cancer has increased, the drug landscape has shifted. Oncology launches are increasingly critical and require a dedicated approach. Here’s what it entails.
Tom Spencer
JULY 14, 2018
1 Pharmaceutical companies are unique in their capacity, due to little regulation and oversight, to raise prices. Pharmaceutical companies focus on a variety of factors when pricing drugs with the main objective of generating the most revenue. Topic: Pharmaceutical Industry in the U.S.”
McKinsey
MAY 10, 2018
Insights on Pharmaceuticals & Medical ProductsMedical information teams can be a source of differentiation if used strategically. But the evolving environment means pharma manufacturers will need to make organizational enhancements to get ahead.
McKinsey
APRIL 6, 2018
Insights on Pharmaceuticals & Medical ProductsThe president of Merck in Japan discusses how healthcare players in the country can capitalize on early detection rates and use collaboration to drive innovation.
McKinsey
APRIL 12, 2018
Insights on Pharmaceuticals & Medical ProductsMedical affairs is poised for a broader, more strategic role. However, leaders will need to ramp up new types of capabilities and talent to achieve this ambition.
McKinsey
MARCH 29, 2018
Insights on Pharmaceuticals & Medical ProductsThe president and CEO of JSR Corporation discusses the company’s plans to grow a global healthcare franchise building from his lessons in the semiconductor industry.
McKinsey
JANUARY 11, 2019
A comprehensive analysis of the business, economic, and public-health impact finds the potential for local production of pharmaceuticals to be a mixed bag. Public Sector Insights
57 
Let's personalize your content